Atrial fibrillation (AF) is the commonest atrial arrhythmia and represents a large burden on
modern health services. Large multicentre randomised trials have demonstrated that a …

Atrial fibrillation (AF) is the most common form of arrhythmia, carrying high social costs. It is
usually first seen by general practitioners or in emergency departments. Despite the …

Atrial fibrillation (AF) represents the most common arrhythmia and is associated with
increased morbidity and mortality generating high social costs. Due to its high prevalence …

Atrial fibrillation is the most common, clinically relevant arrhythmia with a prevalence of
about 2% in the general population. The symptoms in atrial fibrillation are primarily caused …

Atrial fibrillation (AF) is associated with significant morbidity and mortality. There are two
basic approaches to managing AF: slowing the ventricular rate, while allowing the …

Background: Atrial fibrillation is the most common sustained cardiac arrhythmia and has an
important impact on costs of medical assistance. Traditional interventions to convert atrial …

Atrial fibrillation is the most common cardiac rhythm disorder associated with hospitalization.
Two therapeutic options have been available: antiarrhythmic drug therapy, and external or …

Background Antiarrhythmic drugs prolong the atrial action potential and refractory period,
and thereby prevent recurrent atrial fibrillation after cardioversion. The atrial action potential …

Background Atrial fibrillation is the most common type of cardiac arrhythmia and is
associated with elevated rates of stroke, heart failure, hospital admission, and death. Its …

This survey was conducted to provide an insight into the current clinical practice regarding
the use of cardioversion for atrial fibrillation (AF) in Europe. Responses were received from …